OpenURL Connection Search

Select item for more details and to access through your institution.

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo;
- Kawata, Kazuhito
Publication type:
Article
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
Published in:
Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 269, doi. 10.1007/s40121-020-00364-9
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Okushin, Hiroaki;
- Tani, Joji;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Dohmen, Kazufumi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Nouso, Kazuhiro;
- Kariyama, Kazuya;
- Kim, Soo Ryang;
- Kim, Soo Ki;
- Fujioka, Shinichi;
- Mikami, Shigeru;
- Watanabe, Yuto;
- Tamai, Tsutomu;
- Atsukawa, Masanori
Publication type:
Article
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Published in:
2013
By:
- Izumi, Namiki;
- Asahina, Yasuhiro;
- Kurosaki, Masayuki;
- Yamada, Gotaro;
- Kawai, Tsutomu;
- Kajiwara, Eiji;
- Okamura, Yukishige;
- Takeuchi, Takayuki;
- Yokosuka, Osamu;
- Kariyama, Kazuya;
- Toyoda, Joji;
- Inao, Mie;
- Tanaka, Eiji;
- Moriwaki, Hisataka;
- Adachi, Hiroshi;
- Katsushima, Shinji;
- Kudo, Masatoshi;
- Takaguchi, Kouichi;
- Hiasa, Yoichi;
- Chayama, Kazuaki
Publication type:
journal article
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Published in:
Journal of Gastroenterology, 2013, v. 48, n. 3, p. 382, doi. 10.1007/s00535-012-0641-9
By:
- Izumi, Namiki;
- Asahina, Yasuhiro;
- Kurosaki, Masayuki;
- Yamada, Gotaro;
- Kawai, Tsutomu;
- Kajiwara, Eiji;
- Okamura, Yukishige;
- Takeuchi, Takayuki;
- Yokosuka, Osamu;
- Kariyama, Kazuya;
- Toyoda, Joji;
- Inao, Mie;
- Tanaka, Eiji;
- Moriwaki, Hisataka;
- Adachi, Hiroshi;
- Katsushima, Shinji;
- Kudo, Masatoshi;
- Takaguchi, Kouichi;
- Hiasa, Yoichi;
- Chayama, Kazuaki
Publication type:
Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Published in:
Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Tani, Joji;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Nishimura, Takashi;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ogawa, Chikara;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Published in:
Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Masashi Hirooka;
- Kazuya Kariyama;
- Joji Tani;
- Masanori Atsukawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Shinya Fukunishi;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Kazuto Tajiri;
- Hironori Ochi;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Chikara Ogawa;
- Takashi Nishimura;
- Takeshi Hatanaka;
- Hideko Ohama
Publication type:
Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishikawa, Hiroki;
- Nishimura, Takashi;
- Kawata, Kazuhito;
- Kosaka, Hisashi
Publication type:
Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Nishikawa, Hiroki;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Koshiyama, Yuichi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Kawata, Kazuhito
Publication type:
Article
Letter: rising incidence and poor survival in patients with non‐viral HCC – better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed. Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 363, doi. 10.1111/apt.17361
By:
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hiraoka, Atsushi
Publication type:
Article
Editorial: non‐viral hepatocellular carcinoma surveillance—an increasingly severe public health issue. Authors' reply.
Published in:
2022
By:
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hiraoka, Atsushi
Publication type:
Editorial
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088
By:
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Yasuda, Satoshi;
- Nouso, Kazuhiro;
- Kakizaki, Satoru;
- Kumada, Takashi;
- Innes, Hamish;
- Johnson, Philip J.
Publication type:
Article
Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease.
Published in:
Hepatology Research, 2024, v. 54, n. 10, p. 912, doi. 10.1111/hepr.14039
By:
- Nouso, Kazuhiro;
- Kawanaka, Miwa;
- Fujii, Hideki;
- Kariyama, Kazuya;
- Toyoda, Hidenori;
- Iwaki, Michihiro;
- Hayashi, Hideki;
- Oeda, Satoshi;
- Hyogo, Hideyuki;
- Morishita, Asahiro;
- Munekage, Kensuke;
- Kawata, Kazuhito;
- Tsutsumi, Tsubasa;
- Sawada, Koji;
- Maeshiro, Tatsuji;
- Tobita, Hiroshi;
- Yoshida, Yuichi;
- Naito, Masafumi;
- Araki, Asuka;
- Arakaki, Shingo
Publication type:
Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Published in:
Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Published in:
Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
Published in:
Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
By:
- Tanaka, Takaaki;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
By:
- Hatanaka, Takeshi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Published in:
Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hatanaka, Takeshi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Tani, Joji;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma.
Published in:
Hepatology Research, 2021, v. 51, n. 6, p. 694, doi. 10.1111/hepr.13633
By:
- Oyama, Atsushi;
- Nouso, Kazuhiro;
- Yoshimura, Kenichi;
- Morimoto, Yuki;
- Nakamura, Shinichiro;
- Onishi, Hideki;
- Takaki, Akinobu;
- Iwadou, Shouta;
- Kariyama, Kazuya;
- Kuwaki, Kenji;
- Yabushita, Kazuhisa;
- Sakaguchi, Kosaku;
- Toshimori, Jyunichi;
- Kobashi, Haruhiko;
- Moriya, Akio;
- Ando, Masaharu;
- Okada, Hiroyuki
Publication type:
Article
Abnormal fucosylation of alpha‐fetoprotein in patients with nonalcoholic steatohepatitis.
Published in:
Hepatology Research, 2021, v. 51, n. 5, p. 548, doi. 10.1111/hepr.13626
By:
- Nouso, Kazuhiro;
- Furubayashi, Yoshie;
- Kariyama, Kazuya;
- Wakuta, Akiko;
- Miyake, Nozomi;
- Inoue, Kanae;
- Nagai, Yuta;
- Murakami, Shiho;
- Adachi, Takuya;
- Oyama, Atsushi;
- Wada, Nozomu;
- Takeuchi, Yasuto;
- Sakata, Masahiro;
- Yasunaka, Tetsuya;
- Onishi, Hideki;
- Shiraha, Hidenori;
- Takaki, Akinobu;
- Shiota, Shohei;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
Published in:
Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
By:
- Chuma, Makoto;
- Uojima, Haruki;
- Hiraoka, Atsushi;
- Kobayashi, Satoshi;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Hidaka, Hisashi;
- Iwabuchi, Shogo;
- Numata, Kazushi;
- Itobayashi, Ei;
- Itokawa, Norio;
- Kariyama, Kazuya;
- Ohama, Hideko;
- Hattori, Nobuhiro;
- Hirose, Shunji;
- Shibata, Hiroshi;
- Tani, Joji;
- Imai, Michitaka;
- Tajiri, Kazuto;
- Moriya, Satoshi
Publication type:
Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Published in:
Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio
Publication type:
Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
Published in:
Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Tajiri, Kazuto;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ochi, Hironori;
- Hirooka, Masashi;
- Tsutsui, Akemi;
- Shibata, Hiroshi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Kouji;
- Hiasa, Yoichi;
- Michitaka, Kojiro
Publication type:
Article
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E61, doi. 10.1111/hepr.12927
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Kariyama, Kazuya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hirofumi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Koji;
- Kawasaki, Hideki;
- Hiasa, Yoichi;
- Michitaka, Kojiro;
- On Behalf Of The Real‐life Practice Experts For Hcc (relpec) Study Group And Hcc 48 Group (hepatocellular Carcinoma Experts From 48 Clinics)
Publication type:
Article
Modified radiofrequency ablation for the treatment of hepatocellular carcinoma.
Published in:
Hepatology Research, 2016, v. 46, n. 11, p. 1158, doi. 10.1111/hepr.12683
By:
- Nouso, Kazuhiro;
- Oonishi, Ayano;
- Wakuta, Akiko;
- Kariyama, Kazuya
Publication type:
Article
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients.
Published in:
Hepatology Research, 2012, v. 42, n. 11, p. 1058, doi. 10.1111/j.1872-034X.2012.01025.x
By:
- Koda, Masahiko;
- Murawaki, Yoshikazu;
- Hirooka, Yasuaki;
- Kitamoto, Mikiya;
- Ono, Masafumi;
- Sakaeda, Hiroshi;
- Joko, Kouji;
- Sato, Shuichi;
- Tamaki, Katsuyoshi;
- Yamasaki, Takahiro;
- Shibata, Hiroshi;
- Shimoe, Toshinari;
- Matsuda, Tadakazu;
- Toshikuni, Nobuyuki;
- Fujioka, Shin-ichi;
- Ohmoto, Kenji;
- Nakamura, Shinichiro;
- Kariyama, Kazuya;
- Aikata, Hiroshi;
- Kobayashi, Yoshiyuki
Publication type:
Article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
By:
- Tanaka, Kazunari;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.
Published in:
Cancers, 2019, v. 11, n. 2, p. 203, doi. 10.3390/cancers11020203
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kumada, Takashi;
- Kudo, Masatoshi
Publication type:
Article
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Published in:
Liver International, 2024, v. 44, n. 7, p. 1736, doi. 10.1111/liv.15964
By:
- Tatsuya Kikuchi;
- Yasuto Takeuchi;
- Kazuhiro Nouso;
- Kazuya Kariyama;
- Kenji Kuwaki;
- Junichi Toshimori;
- Shota Iwado;
- Akio Moriya;
- Hiroaki Hagihara;
- Hiroyuki Takabatake;
- Toshifumi Tada;
- Tetsuya Yasunaka;
- Masahiro Sakata;
- Masahiko Sue;
- Nozomi Miyake;
- Takuya Adachi;
- Nozomu Wada;
- Hideki Onishi;
- Hidenori Shiraha;
- Akinobu Takaki
Publication type:
Article
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Published in:
Liver International, 2024, v. 44, n. 6, p. 1456, doi. 10.1111/liv.15907
By:
- Kikuchi, Tatsuya;
- Takeuchi, Yasuto;
- Nouso, Kazuhiro;
- Kariyama, Kazuya;
- Kuwaki, Kenji;
- Toshimori, Junichi;
- Iwado, Shota;
- Moriya, Akio;
- Hagihara, Hiroaki;
- Takabatake, Hiroyuki;
- Tada, Toshifumi;
- Yasunaka, Tetsuya;
- Sakata, Masahiro;
- Sue, Masahiko;
- Miyake, Nozomi;
- Adachi, Takuya;
- Wada, Nozomu;
- Onishi, Hideki;
- Shiraha, Hidenori;
- Takaki, Akinobu
Publication type:
Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
Published in:
Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ohama, Hideko;
- Kawata, Kazuhito
Publication type:
Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ohama, Hideko;
- Tada, Fujimasa;
- Nouso, Kazuhiro
Publication type:
Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 181, doi. 10.1159/000514174
By:
- Kudo, Masatoshi;
- Kawamura, Yusuke;
- Hasegawa, Kiyoshi;
- Tateishi, Ryosuke;
- Kariyama, Kazuya;
- Shiina, Shuichiro;
- Toyoda, Hidenori;
- Imai, Yasuharu;
- Hiraoka, Atsushi;
- Ikeda, Masafumi;
- Izumi, Namiki;
- Moriguchi, Michihisa;
- Ogasawara, Sadahisa;
- Minami, Yasunori;
- Ueshima, Kazuomi;
- Murakami, Takamichi;
- Miyayama, Shiro;
- Nakashima, Osamu;
- Yano, Hirohisa;
- Sakamoto, Michiie
Publication type:
Article
Reply to the Letter "Comment on Regarding Manuscript 'Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies'".
Published in:
2021
By:
- Kazuhiro Nouso;
- Kazuya Kariyama
Publication type:
Letter to the Editor
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Kazuya Kariyama;
- Joji Tani;
- Shinya Fukunishi;
- Masanori Atsukawa;
- Masashi Hirooka;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Kazuto Tajiri;
- Noritomo Shimada;
- Hiroshi Shibata;
- Hironori Ochi;
- Kazuhito Kawata;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Hideko Ohama
Publication type:
Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
Published in:
Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Hiraoka, Atsushi;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kuzuya, Teiji;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Shimada, Noritomo;
- Kudo, Masatoshi;
- Kumada, Takashi
Publication type:
Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Published in:
Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
By:
- Nouso, Kazuhiro;
- Shiota, Shohei;
- Fujita, Rio;
- Wakuta, Akiko;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Atsukawa, Masanori;
- Tani, Joji;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Tajiri, Kazuto;
- Kaibori, Masaki;
- Hirooka, Masashi;
- Itobayashi, Ei;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Fukunishi, Shinya;
- Tsuji, Kunihiko
Publication type:
Article
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17559, doi. 10.1002/cam4.6369
By:
- Takeuchi, Yasuto;
- Nouso, Kazuhiro;
- Fujioka, Shin‐ichi;
- Kariyama, Kazuya;
- Kobashi, Haruhiko;
- Uematsu, Shuji;
- Moriya, Akio;
- Hagihara, Hiroaki;
- Takabatake, Hiroyuki;
- Nakamura, Shinichiro;
- Yabushita, Kazuhisa;
- Kikuchi, Tatsuya;
- Oyama, Atsushi;
- Adachi, Takuya;
- Wada, Nozomu;
- Onishi, Hideki;
- Shiraha, Hidenori;
- Takaki, Akinobu
Publication type:
Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Published in:
Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Naganuma, Atsushi;
- Tada, Toshifumi;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Tanaka, Takaaki;
- Nagano, Takuya;
- Imai, Michitaka;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro
Publication type:
Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Published in:
Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article

Found: 79